B2DB — Who said what, where, and when

Joel M. Gelfand, MD, MSCE, FAAD

Chief Medical Editor Healio Dermatology, Healio

Joel M. Gelfand, MD, MSCE, FAAD is listed as Chief Medical Editor Healio Dermatology, Healio. Joel is scheduled to speak at American Academy of Dermatology Annual Meeting 2027 on 20 March 2027.

Compiled from published conference agendas; not yet confirmed by Joel. Is this you? Claim this profile.

About

Joel M. Gelfand MD MSCE is the James J. Leyden Endowed Professor of Clinical Investigation, and Professor (with tenure) of Dermatology and Epidemiology, Director (co-founding) of the Center for Clinical Sciences in Dermatology, and Director of the Psoriasis and Phototherapy Treatment Center at the University of Pennsylvania Perelman School of Medicine. He is an internationally recognized expert in psoriasis, epidemiology, drug safety, and clinical trials. Dr. Gelfand is the author of over 330 scientific publications cited over 49,000 times (H index 108). His research program was the first to establish that psoriasis patients have an increased risk of cardiovascular disease and mortality. He conducts patient centered research through the Dermatology Clinical Effectiveness Research Network (DCERN), which he founded in 2009 and involves over 50 dermatology practices in the US. He has received investigator-initiated research grants from NIH, FDA, PCORI, Foundations, and industry. He has gi

Upcoming

American Academy of Dermatology Annual Meeting 2027 19 March 2027 – 23 March 2027

Spoke alongside

People who have shared a session with Joel at events on B2DB.

and 1 more people